OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Imatinib
19 minutes
Posted May 9, 2019 at 4:00 pm.
0:00
19:14
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
The Foundations of OncoPharm returns with imatinib, the 1st TKI. Discussion includes its history (and how imatinib's Phase I study almost didn't happen), uses, and toxicity.
Previous
Updates: bb2121 (myeloma CAR-T) and 1st line use of ivosidenib in AML
Next
May Approvals, More Questions
← See all 273 episodes of OncoPharm